A. Friedman
Physiology · with Bedi · 2007
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Physiology — 6 citations into it; #1,694 of 2,276 by trust here, #1,457 by citations
Whom A. Friedman trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts A. Friedman overall
Papers from A. Friedman's perspective
Ordered by how strongly the researchers A. Friedman trusts endorse each paper. Same corpus, a different order for every researcher.
- Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition (Nature Medicine)
- Neurovascular mechanisms of Alzheimer's neurodegeneration. (Trends in Neurosciences)
- Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. (Journal of Clinical Investigation)
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain (Nature Medicine)
- Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (Journal of Neuroscience)
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function (Science)
- APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy (Nature Genetics)
- Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. (Proceedings of the National Academy of Sciences of the United States of America)
- Multidrug resistance in cancer: role of ATP–dependent transporters (Nature Reviews. Cancer)
- Polymorphisms in Human MDR1 (P‐glycoprotein): Recent Advances and Clinical Relevance (Clinical pharmacology and therapy)